Pharmacological Study That Measures Omeprazole Effect on Aspirins Absorption in Healthy Volunteers
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01061034|
Recruitment Status : Completed
First Posted : February 2, 2010
Results First Posted : February 2, 2010
Last Update Posted : February 2, 2010
Aspirin is a weak acid that crosses the gastric and intestinal mucosa by passive diffusion while in its lipophilic nature.Omeprazole, a proton pump inhibitor, inhibits gastric acid secretion.
We assumed that omeprazole inhibits aspirin absorption, thus reducing its action on platelets.
healthy volunteers, with no known peptic disease or bleeding disorders will be enrolled.
All volunteers will receive 7 days of Aspirin (100mg) alone, followed by 14 days of Aspirin and Omeprazole 20mg twice daily for 3 days and then 20mg once daily.
Blood levels of Aspirin will be determined by High performance liquid chromatography (HPLC), 0, 1, 2, 4, 6, 10, 24 hours after the administration of Aspirin alone on day 7 and Aspirin plus Omeprazole on day 21.
Platelet function tests will be determined by platelet-rich plasma aggregometry in response to Arachidonic acid (500mg/ml), Ristocetin (1.5mg/ml) and Adenosine 5'-diphosphate (20mM) on day 0 as baseline and on day 7 and 21 of the study.
|Condition or disease||Intervention/treatment||Phase|
|Aspirin Blood Level Proton Pump Inhiditor Treatment||Drug: aspirin and omeprazole||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||9 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||The Effect of Proton Pump Inhibitor (Omeprazole) on Acetosalisylic Acid Absorption.|
|Study Start Date :||March 2007|
|Actual Primary Completion Date :||June 2007|
|Actual Study Completion Date :||June 2007|
Drug: aspirin and omeprazole
- Aspirin Level in Blood (Area Under the Curve) [ Time Frame: on day 7,on day 21 ]
- Platelet Function Tests [ Time Frame: on day 0 as a baseline and on day 7 and 21 of the study. ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01061034
|Assaf Harofeh Medical Center|
|Study Director:||ahuva golik, prop.||asaf-harofemedical center|